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THE MANAGEMENT OF HEMATOLOGIC DISEASES
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Angelita Habr-Gama and Joaquim José Gama-Rodrigues
SAPUCAHY MV et al. - Laparoscopic versus open splenectomy in the management of hematologic diseases. Rev. Hosp.
Clín. Fac. Med. S. Paulo 58 (5):243-249, 2003.
Splenectomy is the best available treatment for severe forms of hereditary spherocytosis, idiopathic thrombocytopenic
purpura, and other hematologic conditions when these prove refractory to conservative management. It has been employed
for many decades with low mortality and favorable remission rates.
The use of laparoscopic splenectomy in recent years has been rapidly and even enthusiastically adopted in this field.
However, the exact role of laparoscopic versus open surgery for hematologic diseases is still debated. In this study of 58
adult patients, laparoscopic procedures were compared with conventional splenectomies for similar indications.
METHODS: All patients were operated on within an 8-year period. Subjects underwent similar procedures under the
supervision of the same surgical school and were compared regarding age, gender, body mass index, and diagnosis.
Laparoscopically managed cases (Group I, n = 30) were prospectively followed according to a written protocol, whereas the
same investigation was retrospectively done with regard to traditional laparotomy (Group II, n = 28).
Methods included general and demographic findings, duration and technical steps of operation, blood loss, weight of
spleen, need for conversion (in minimally invasive subjects), intraoperative and postoperative complications, time until
realimentation, postoperative hospitalization, mortality, and late follow-up including recurrence rate.
RESULTS: Idiopathic thrombocytopenic purpura was the surgical indication in over 50% of the patients in both
groups, but familial spherocytosis, thalassemia, myelodysplasia, and lymphomas were also represented in this series.
Laparoscopic procedures took more time to perform (P = 0.004), and postoperative hospitalization was 2 days shorter, but
this difference was not statistically significant. Postoperative hematocrit and volume of blood transfusions was equivalent,
although the laparoscopic cases had a somewhat lower preoperative hematocrit (NS) and displayed better recovery for this
measurement (P = 0.03). More patients in Group I were able to accept oral food on the first day than subjects undergoing
conventional operations (P < 0.05). Relatively few conversions were necessary during the minimally invasive surgeries
(13.3%), and postoperative early and late complications as well as recurrences occurred in similar proportions. Also, the
mean weight of the spleen was not statistically different between the groups, although there was a marked numerical
tendency toward larger masses in conventional procedures. No spleen in Group I exceeded 2.0 kg, whereas in Group II values
up to 4.0 kg occurred, and the mean weight was 50% higher in the latter group.
CONCLUSIONS: 1) Minimally invasive splenectomy was essentially comparable to open surgery with regard to
safety, efficacy, and late results; 2) Advantages concerning shorter postoperative hospitalization could not be shown,
despite earlier food intake and a non-significant tendency toward earlier discharge; 3) This new modality should be
considered an option in cases of hematologic conditions whenever the spleen is not hugely enlarged.
DESCRIPTORS: Splenectomy. Laparoscopic operation. Hereditary spherocytosis. Idiopathic thrombocytopenic
purpura. Hematologic disease.
Modern laparoscopic surgery was
introduced by Mouret who, in 1987,
removed a diseased gallbladder in
Lyon, France employing the instru-
ments of a fellow gynecologist1. A few
months later Dubois2,3 in Paris not
only announced his own laparoscopic
cholecystectomy, but also the estab-
lishment of a systematic training pro-
gram with laboratory animals, which
was soon emulated in other parts of the
world. Within just a few more years, a
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whole new specialty would be an-
nounced, with video-laparoscopy, spe-
cial instruments, insufflators and light
sources, and successful followers in
virtually all continents4.
The advantages of reduced trauma,
less postoperative pain, earlier hospi-
tal discharge, and superior esthetic re-
sults were not overlooked by other sur-
gical branches, and soon the laparos-
copic method found supporters in urol-
ogy, pediatric surgery, thoracic and
cardiovascular surgery, plastic surgery,
endocrinologic surgery, bariatric sur-
gery, orthopedics, and other areas.
Within the abdomen, not only hol-
low viscera but also solid organs were
approached by this minimally invasive
method, and the spleen was not to be
an exception. As early as in 1993, au-
thors such as Flowers5 and Lefor et al.6,7
were applying the new technique for
benign and malignant splenic condi-
tions.
Since the spleen is the major site
for blood cell destruction both in
physiologic and pathologic circum-
stances, splenectomy has been proved
useful for severe aplastic, autoimmune,
and cryptogenic anemia; thrombocy-
topenia or neutropenia; hypersplen-
ism; bone marrow dysfunction; and
miscellaneous hematologic diseases
that do not adequately respond to phar-
macological management8. These in-
clude congenital spherocytosis, idi-
opathic thrombocytopenic purpura,
autoimmune hemolytic anemia, major
thalassemia, idiopathic neutropenia,
myelodysplasia, hypersplenism,
Hodgkin´s lymphoma, Gaucher´s dis-
ease, and splenic sarcoidosis5-9.
In spite of multiple potential indi-
cations, the initial experience with
laparoscopic splenectomy was usually
focused on idiopathic thrombocyto-
penic purpura because the spleen is not
considerably enlarged in this circum-
stance9.
Indeed, voluminous spleens may
pose a challenge to minimally invasive
procedures because of increased
chances of hemorrhage and need for
conversion to the open approach. These
challenges stem from technical difficul-
ties in dissecting enlarged splenic ves-
sels, intrinsic bleeding tendencies
linked to low thrombocyte counts, or
possible coagulation factor deficits, and
occsional focal infarctions that produce
adhesions and anatomical distortions.
Nevertheless, well-trained teams have
demonstrated the feasibility of remov-
ing even massive organs when the tech-
nique is carefully employed10.
Of course, laparoscopic splenec-
tomy may be used for trauma, cysts,
aneurisms of the splenic artery, benign
or malignant tumors, and other
nonhematologic situations. Experi-
ence with small children is also grow-
ing, but these are out of the scope of
this study11.
The current series aims to retro-
spectively compare indications, re-
sults, and complications of
laparoscopic splenectomy exclusively
in adolescents and adults suffering
from hematologic diseases, employing
as controls a similar population under-
going open surgery within an 8-year
period (November 1993 to June 2001).
PATIENTS  AND  METHODS
Clinical charts from 3 hospitals (n=
120) were reviewed for criteria of in-
clusion and exclusion, of which 58
were adequate. All patients had been
operated on in accordance with the
principles and routines and under the
supervision of our Division, and most
of the laparoscopic procedures were
performed by the first author (67%).
Criteria for inclusion:
Age >13 years, males or females
Confirmed hematologic diagnosis
Unresponsive to pharmacological
therapy
Elective procedure
Criteria for exclusion:
Splenectomy for portal hypertension
Splenectomy during gastric cancer
surgery
Splenectomy due to trauma or other
nonhematologic diseases
Re-operations because of accessory
spleen
Procedures carried out by external
teams
Surgical technique: Laparoscopic
operations employed 4 (70% of the pa-
tients) or 5 trocars (30.0% of the group)
via the transperitoneal route (Fig. 1),
and as soon as the gastrocolic ligament
was opened, preliminary ligature of the
splenic artery was carried out. A plastic
bag was employed to protect the ab-
dominal cavity from implants, to per-
mit cutting or slicing of larger organs
and to enable the surgeon to easily and
safely retrieve the splenic mass.
Open splenectomy was equally
performed via the peritoneal cavity
adopting the initial ligature of the
splenic artery. Vascular ligatures and
dissections were done from the lower
pole upwards, after the omental cavity
was exposed. In both modalities, ac-
cessory spleens were carefully located
and removed, and external drainage
was an option, depending on the lo-
cal conditions.
Methods: Variables included clini-
cal and demographic information, sur-
gical findings (operative time and need
for blood transfusions, weight of the
spleen, drainage and other technical
maneuvers), time to postoperative
food intake, preoperative and postop-
erative hematologic profile, immediate
and late complications, and recurrence
of the disease.
Stratification: Patients were di-
vided into Laparoscopic (Group I,
n=30) and Conventional (Group II, n=
28) populations, according to the per-
formed procedure.
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Randomization: No randomization
could be applied, since this was a ba-
sically retrospective study and all op-
erations had been performed already.
Statistical analysis: Discrete meas-
urements were compared by means of
a chi-square analysis and Fisher’s ex-
act test, whereas quantitative variables
were first submitted to variance and
normality assessment using Levene as
well as Kolmogorov-Smirnov tests.
Actual differences were estimated by
Student’s t test or Mann-Whitney test
as appropriate. A significance limit of
5% (P <0.05) was adopted.
Preliminary findings: The age in
both groups was similar (40.6 ± 18.5 vs.
38.6 ± 17.5, NS), females were the ma-
jority in both contexts (19/30 vs. 20/28,
NS), and body mass index was compa-
rable (24.8 ± 3.2 vs. 25.7 ± 5.2 kg/m2,
NS). Idiopathic thrombocytopenic pur-
pura was the most common entity in both
groups (17/30 vs. 17/28, NS), followed
by familial spherocytosis, hemolytic
anemia, myelodysplasia, lymphoma,
and miscellaneous conditions.
In addition to splenectomy, hepatic
biopsy (3/30 vs. 6/28, NS) and chole-
cystectomy (5/30 vs. 6/28, NS) were
simultaneously performed in this se-
ries. All patients received antipneu-
mococcus vaccine in the preoperative
period.
RESULTS
Laparoscopic procedures took
longer than standard splenectomy (261
± 83 vs. 184 ± 71 minutes, P =
0.0004). Hospital stay was numerically
shorter in Group I (5.1 ± 2.4 vs. 7.1 ±
8.1 days), but statistical confirmation
was not obtained. In a few cases, pre-
liminary ligature of the splenic artery
was not performed by the surgeon (8/
30 vs. 3/28, NS), whereas drains were
more often utilized in the minimally
invasive procedure than in open sur-
gery (15/30 vs. 4/28, P = 0.009).
The mean weight of the spleen was
40% smaller in Group I than II (478 ±
489 vs. 789 ± 1072 g), and maximum
weight was also quite different (2000
vs. 3980 g), but statistical difference
could not be demonstrated. On the
other hand, the laparoscopic route was
as efficient as the conventional ap-
proach for identifying and eliminating
accessory spleens (5/30 vs. 2/28, NS).
In 4 patients, conversion to open
surgery was required (13.3%). Two of
these were secondary to persistent
hemorrhage; a third case had firm ad-
hesions between the spleen and the
diaphragm due to previous infarction
and displayed heart arrhythmia when-
ever maneuvers to free the organ were
attempted; and 1 subject exhibited
strongly adherent and confluent lymph
nodes and areas of fibrosis surround-
ing the hilar vessels of the spleen, thus
preventing dissection of this area by
the laparoscopic method.
The most frequent intraoperative
complication in both groups was
bleeding, and comparable numbers of
patients in both populations required
blood transfusions (12/30 vs. 7/28,
NS). Minor laceration of the stomach
was seen in an open case, and was im-
mediately repaired, and a minor skin
burn due to leak of current from the
laparoscopic cautery was identified in
Group I, without differences in total
intraoperative complications between
the populations (8/30 vs. 2/28, NS).
Again, early postoperative (up to hos-
pital discharge) and late complications
occurred in equivalent proportions (re-
spectively 7/30 vs. 12/28, NS and 3/
30 vs. 7/28, NS).
Serious early complications in
Group I were represented by 1 episode
of bleeding through the drain that re-
quired re-operation and 1 death on the
2nd postoperative day in a 63 year-
old-male due to necroscopically con-
firmed myocardial infarction. In Group
II subjects, 3 re-operations were nec-
essary, 1 due to bleeding with
hemorrhagic shock, another connected
to a subphrenic abscess, and the last
one because of abdominal dehiscence
and evisceration.
Significant late complications in a
Figure 1 - Trocar placement for laparoscopic splenectomy: (1) a 10-mm camera port at the
umbilicus; (2) a 5-mm working port half way between the umbilicus and the xiphoid process
in the midline; (3) a 5-mm hepatic retractor port at the xiphoid process; (4) a 12-mm port site
was enlarged to 2 cm and used as the extraction incision to remove spleen.
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laparoscopically managed patient in-
cluded 1 wound abscess that was
drained on the outpatient visit, and 3
incisional hernias occurred in cases
managed by conventional surgery.
The laparoscopic procedure permit-
ted earlier food intake by the patients
(77% accepted food on the first post-
operative day, versus 43% in the con-
trol group, P =0.05). Also recovery of
hematocrit values was more effective in
the laparoscopic group (P = 0.033),
whereas no differences were observed in
platelet counts. Within the average fol-
low-up period of 2 years, hematologic
recurrences were uncommon in both
groups (4/30 vs. 3/28, NS).
DISCUSSION
Not many new concepts in medi-
cine are truly paradigmatic, and few
have been recognized as more practi-
cal in recent years than the laparos-
copic method of performing surgery.
Laparoscopic surgery clearly passes
the test of great innovations, which is
the criterion of before and after. In-
deed, few people would question that
modern surgical treatment can be clas-
sified as before and after the advent of
laparoscopic procedures.
This change was surely record-set-
ting regarding elapsed time between
first attempts and definitive interna-
tional acceptance. No more than a cou-
ple of years separated the pioneering
reports of the French precursors1,2 and
the widespread adoption of the tech-
nique by multiple specialties and
countless services and countries. With
regard to laparoscopic splenectomy, a
similar phenomenon occurred: the first
2 reports appeared between 1991 and
199212,13, and in 199814 the new mo-
dality was already praised as the “gold
standard” for surgical management of
the spleen in benign hematologic dis-
eases whenever the organ is not much
enlarged.
In spite of the enthusiasm of the
authors mentioned above14, this is a
complex subject, and it is likely that
for some years to come the optimal al-
ternative for performing splenectomy
in certain circumstances will still be
debated.
Baccarani et al.15 reviewed 104 pa-
pers published between 1989 and
1998, many of which compared open
versus laparoscopic splenectomy. In-
terestingly, none of the studies was
prospective, with most of them using
nonrandomized controls as in the
present experience. Among these in-
vestigations, 41 fulfilled the criteria of
inclusion, representing over 600 lapa-
roscopic splenectomies. The principal
advantages of the new option were ear-
lier restoration of gastrointestinal func-
tion and shorter hospital stay.
Klingler et al.16 attempted a simi-
lar collective review of 21 reports, of
which 6 were comparative. Neverthe-
less, definitive conclusions were hard
to come by, since the size of the spleen
was not homogeneous among laparos-
copic and conventional groups. Simi-
larly to the current investigation, most
surgeons preferred the open approach
for very large spleens and laparoscopic
route for smaller ones.
In the present protocol, great care
was directed toward homogenization
of the 2 series, and they were certainly
comparable with regard to biodemo-
graphic features, hematologic diagno-
sis, and general surgical management.
A limit in size of a laparoscopically re-
movable spleen was not adopted, as
suggested by Poulin & Thibault17,
namely of up to 20 cm length or 1 kg.
These precautions notwithstanding, a
tendency toward clustering of the big-
ger spleens in Group II occurred, with
greater amounts of preoperative throm-
bocytopenia in this population.
Surgical maneuvers and allied care
were as similar as possible for the 2
modalities, including general tech-
nique, vaccine use, preliminary liga-
ture of the splenic artery, and blood
transfusions. However, a discrepancy
was noted with regard to drainage,
which was more frequent in the lapa-
roscopic group.
Operative time was expected to be
longer for the laparoscopic approach,
and that was really the case. A few
words are required to explain the ac-
tual duration numbers, which ex-
ceeded those published in other se-
ries15,16 for both open and minimally
invasive routes. The longer duration
times were surely due to the participa-
tion in all operations of junior resi-
dents, as well as to the fact that sev-
eral of the laparoscopic procedures
were done at a time when this tech-
nique was still new in the service, thus
coinciding with the learning curve of
the hospital team.
No clear pattern was noted concern-
ing the amount of blood loss or volume
of transfusions required, and interpreta-
tion of these values are clouded any-
way by circumstances such as size of
the spleen, technical difficulties during
operation, and the baseline coagulation
status of the patient. In accordance with
a number of authors18-20, no differences
were detected between the groups. It is
worthwhile to emphasize that hema-
tocrit values recovered more effectively
after laparoscopy, thus suggesting less
operative hemorrhage than in the open
modality.
General morbidity and mortality
are usually reported as worse when
laparotomy instead of laparoscopy is
utilized19-21, but statistical confirmation
is not always achieved. In the current
series, no statistical difference could be
demonstrated when these variables
were examined. One highly relevant
pitfall is the need for conversion to
open surgery, and in this experience,
conversion was required in 13.3% of
the operations. That is a larger propor-
tion than has been reported by some
authors16 but is perfectly compatible
with some other reports18,19,22.
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Several of these investigations in-
dicate both earlier refeeding and ear-
lier hospital discharge when laparos-
copic resection is provided16,18,19, but
in the current study, only the former
advantage was evident. It is expected
that minimally invasive surgery should
elicit a more modest neuroendocrine
response and also less postoperative
ileus, thus explaining rapid restoration
of gastrointestinal function, and this
was clearly the case in this series. On
the other hand, postoperative hospi-
talization is usually linked to general
morbidity. Since morbidity was equiv-
alent in both situations, the same out-
come should be anticipated for time
until discharge.
Accessory spleens and recurrences
failed to display any differences be-
tween the groups. These are poten-
tially important findings, since video-
laparoscopy has been suspected as less
effective in the search and identifica-
tion of accessory spleens16. Unrecog-
nized splenic tissue is a cause for con-
cern and may explain early recurrence
of the hematologic disease, but fortu-
nately, all analyzed procedures were
equally successful in this regard.
Since the first laparoscopic sple-
nectomy performed in Brazil in 199323,
few reports have been published in
this country24-27. However, a question-
naire was submitted to practicing
laparoscopists by the Brazilian Soci-
ety of Laparoscopic Surgery28 polling
the results of 408 procedures. Yet it is
difficult to compare our results with
these findings, since they were not sys-
tematic investigations, and the ques-
tionnaire was responded to by a non-
representative sample of Brazilian pro-
fessionals.
In any case, they bear witness to the
growing interest in this modality and
to the rapid increase in the number of
laparoscopic splenectomies performed
in this country. It is not unreasonable
to foresee that technical obstacles that
were listed here will progressively di-
minish in the future, thus rendering
video-laparoscopy an even more ap-
pealing option in the treatment of
chronic hematologic diseases.
CONCLUSIONS
1) Laparoscopic procedures were
indicated for smaller spleens with less
affected platelet counts;
2) Hematocrit recovery suggested
less blood loss during video-laparos-
copy, although these operations took
longer to perform;
3) Laparoscopically managed pa-
tients accepted food earlier, but mor-
bidity, mortality, and duration of hos-
pitalization were similar in both
groups;
4) Laparoscopic procedures were as
effective as open procedures in the re-
moval of accessory spleens and pre-
vention of postoperative recurrence;
5) Conversion to laparotomy was
required in 13% of the laparoscopic
procedures; however, the final outcome
of the patients was not adversely af-
fected by this change;
6) It can be affirmed that the lapa-
roscopic splenectomy is a valid and
safe option for the treatment of chronic
hematologic conditions whenever the
spleen is not massively enlarged.
RESUMO
SAPUCAHY MV e col. - Esplenec-
tomia laparoscópica versus aberta
no tratamento de doenças hema-
tológicas. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58 (5):243-249,
2003.
A esplenectomia é o melhor trata-
mento disponível para formas graves
de esferocitose hereditária, púrpura
trombocitopênica idiopática e outras
entidades hematológicas refratárias à
abordagem conservadora. Ela tem sido
empregada há muitas décadas com
baixa mortalidade e taxas de remissão
favoráveis.
A alternativa de esplenectomia
laparoscópica em anos recentes foi
adotada rapidamente e até entusiasti-
camente, todavia o papel exato das in-
tervenções abertas em contraposição às
laparoscópicas para doenças hemato-
lógicas ainda é objeto de debate. Num
estudo de 58 pacientes adultos, os pro-
cedimentos laparoscópicos foram com-
parados com as esplenectomias con-
vencionais em indicações semelhantes.
MÉTODOS: Todos os pacientes
foram operados num período de 8
anos. Eles foram submetidos a opera-
ções análogas sob a supervisão da mes-
ma escola cirúrgica e eram compará-
veis no tocante a idade, sexo, índice
de massa corporal e diagnóstico. Os
casos abordados laparoscopicamente
(Grupo I, n= 30) foram seguidos
prospectivamente de acordo com pro-
tocolo escrito, ao passo que a mesma
investigação foi aplicada retrospecti-
vamente no que concerne aos doentes
de esplenectomia aberta (Grupo II, n=
28).
Os métodos incluíram achados ge-
rais e demográficos, duração e passos
técnicos da cirurgia, perda sangüínea,
peso do baço, necessidade de conver-
são (nos casos minimamente invasi-
vos), complicações intra e pós-opera-
tórias, tempo para realimentação,
hospitalização pós-operatória, mortali-
dade e seguimento tardio, incluindo
recidivas.
RESULTADOS: A púrpura trom-
bocitopênica idiopática foi a indica-
ção cirúrgica em mais de 50% dos en-
fermos de ambos os grupos, entretan-
to esferocitose familiar, talassemia,
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mielodisplasia e linfomas também es-
tavam representados nesta série. As in-
tervenções laparoscópicas demoraram
mais (p=0,004) e sua hospitalização
pós-operatória foi dois dias mais bre-
ve, porém esta diferença não foi esta-
tisticamente significativa. O hema-
tócrito pós-operatório e o volume de
transfusões foram equivalentes, no en-
tanto os casos laparoscópicos exibiam
um hematócrito pré-operatório ligeira-
mente inferior (NS) e a recuperação
desta variável foi melhor (p=0,03).
Mais pacientes do Grupo I tolera-
ram dieta oral no primeiro dia que ca-
sos abordados convencionalmente
(p<0,05). Relativamente poucas con-
versões foram necessárias no decurso
das laparoscopias (13,3%), e as com-
plicações pós-operatórias precoces e
tardias assim como as recidivas distri-
buíram-se de forma eqüitativa. Tam-
bém não foi possível demonstrar-se di-
ferenças no peso do baço, ainda que
no Grupo I nenhum órgão excedesse a
2,0 kg, sendo que no Grupo II este va-
lor chegou até 4,0 kg, notando-se ain-
da que o peso médio foi 50% mais ele-
vado nesta última população.
CONCLUSÕES: 1) A esplenec-
tomia minimamente invasiva foi essen-
cialmente comparável à variante aber-
ta no tocante à segurança, eficácia e
resultados tardios; 2) Não foi possível
comprovar-se vantagens relativas à
menor hospitalização pós-operatória,
embora a realimentação fosse mais pre-
coce e houvesse uma tendência não-
significativa para alta hospitalar ante-
cipada; 3) Esta nova modalidade deve
ser considerada uma excelente opção
para casos de moléstias hematológicas
sempre que o baço não estiver forte-
mente aumentado.
DESCRITORES: Esplenectomia.
Operação laparoscópica. Esferoci-
tose hereditária. Púrpura trombo-
citopênica idiopática. Doença hema-
tológica.
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